{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:09:16Z","timestamp":1764083356218,"version":"3.45.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00707-z","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T02:14:20Z","timestamp":1764036860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, pharmacological evaluation and computational modeling of 4-formyl-2-nitrophenyl quinoline-8-sulfonate derived thiosemicarbazones as antidiabetic agents"],"prefix":"10.1007","volume":"40","author":[{"given":"Muhammad","family":"Tayyab","sequence":"first","affiliation":[]},{"given":"Khalid","family":"Mahmood","sequence":"additional","affiliation":[]},{"given":"Khawar","family":"Abbas","sequence":"additional","affiliation":[]},{"given":"Farhan","family":"Siddique","sequence":"additional","affiliation":[]},{"given":"Nastaran","family":"Sadeghian","sequence":"additional","affiliation":[]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[]},{"given":"Maryam","family":"Bashir","sequence":"additional","affiliation":[]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[]},{"given":"Abdullah K.","family":"Alanazi","sequence":"additional","affiliation":[]},{"given":"Mostafa A.","family":"Ismail","sequence":"additional","affiliation":[]},{"given":"Xianliang","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"707_CR1","doi-asserted-by":"publisher","first-page":"111738","DOI":"10.1016\/j.fct.2020.111738","volume":"145","author":"U Hossain","year":"2020","unstructured":"Hossain U, Das AK, Ghosh S, Sil PC (2020) An overview on the role of bioactive \u03b1-glucosidase inhibitors in ameliorating diabetic complications. Food Chem Toxicol 145:111738","journal-title":"Food Chem Toxicol"},{"key":"707_CR2","doi-asserted-by":"publisher","first-page":"838027","DOI":"10.3389\/fendo.2022.838027","volume":"13","author":"S Safiri","year":"2022","unstructured":"Safiri S, Karamzad N, Kaufman JS, Bell AW, Nejadghaderi SA, Sullman MJ, Moradi-Lakeh M, Collins G, Kolahi A-A (2022) Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990\u20132019: results from the global burden of disease study 2019. Front Endocrinol 13:838027","journal-title":"Front Endocrinol"},{"issue":"20","key":"707_CR3","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.3390\/plants11202722","volume":"11","author":"H Kashtoh","year":"2022","unstructured":"Kashtoh H, Baek K-H (2022) Recent updates on phytoconstituent alpha-glucosidase inhibitors: an approach towards the treatment of type two diabetes. Plants 11(20):2722","journal-title":"Plants"},{"issue":"4","key":"707_CR4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11101-021-09773-1","volume":"21","author":"AM Dirir","year":"2022","unstructured":"Dirir AM, Daou M, Yousef AF, Yousef LF (2022) A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochem Rev 21(4):1049\u20131079","journal-title":"Phytochem Rev"},{"key":"707_CR5","doi-asserted-by":"publisher","first-page":"115119","DOI":"10.1016\/j.ejmech.2023.115119","volume":"249","author":"A Mushtaq","year":"2023","unstructured":"Mushtaq A, Azam U, Mehreen S, Naseer MM (2023) Synthetic \u03b1-glucosidase inhibitors as promising anti-diabetic agents: recent developments and future challenges. Eur J Med Chem 249:115119","journal-title":"Eur J Med Chem"},{"key":"707_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ijbiomac.2018.08.001","volume":"119","author":"\u0130 Gul\u00e7in","year":"2018","unstructured":"Gul\u00e7in \u0130, Taslimi P, Ayg\u00fcn A, Sadeghian N, Bastem E, Kufrevioglu OI, Turkan F, \u015een F (2018) Antidiabetic and antiparasitic potentials: inhibition effects of some natural antioxidant compounds on \u03b1-glycosidase, \u03b1-amylase and human glutathione S-transferase enzymes. Int J Biol Macromol 119:741\u2013746","journal-title":"Int J Biol Macromol"},{"issue":"10394","key":"707_CR7","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/S0140-6736(23)00223-4","volume":"401","author":"T Quattrin","year":"2023","unstructured":"Quattrin T, Mastrandrea LD, Walker LS (2023) Type 1 diabetes. Lancet 401(10394):2149\u20132162","journal-title":"Lancet"},{"issue":"21","key":"707_CR8","first-page":"2767","volume":"49","author":"NP Prajapati","year":"2019","unstructured":"Prajapati NP, Patel HD (2019) Novel thiosemicarbazone derivatives and their metal complexes: recent development. Synth Commun 49(21):2767\u20132804","journal-title":"Synth Commun"},{"key":"707_CR9","doi-asserted-by":"publisher","first-page":"154887","DOI":"10.1016\/j.phymed.2023.154887","volume":"126","author":"X Cheng","year":"2024","unstructured":"Cheng X, Huang J, Li H, Zhao D, Liu Z, Zhu L, Zhang Z, Peng W (2024) Quercetin: a promising therapy for diabetic encephalopathy through Inhibition of hippocampal ferroptosis. Phytomedicine 126:154887","journal-title":"Phytomedicine"},{"key":"707_CR10","doi-asserted-by":"crossref","unstructured":"Peng Q, Zhang H, Li Z (2025) KAT2A-mediated H3K79 succinylation promotes ferroptosis in diabetic nephropathy by regulating SAT2. Life Sci 123746","DOI":"10.1016\/j.lfs.2025.123746"},{"issue":"4","key":"707_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00011-019-01220-4","volume":"68","author":"W Mi","year":"2019","unstructured":"Mi W, Xia Y, Bian Y (2019) The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis. Inflamm Res 68(4):275\u2013284","journal-title":"Inflamm Res"},{"key":"707_CR12","doi-asserted-by":"publisher","first-page":"160629","DOI":"10.1016\/j.cej.2025.160629","volume":"507","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Nie C, Wang Z, Lan F, Wan L, Li A, Zheng P, Zhu W, Pan Q (2025) A Spatial confinement biological heterogeneous cascade nanozyme composite hydrogel combined with nitric oxide gas therapy for enhanced treatment of psoriasis and diabetic wound. Chem Eng J 507:160629","journal-title":"Chem Eng J"},{"key":"707_CR13","doi-asserted-by":"publisher","first-page":"140070","DOI":"10.1016\/j.molstruc.2024.140070","volume":"1321","author":"N Ullah","year":"2025","unstructured":"Ullah N, Alam A, T\u00fcz\u00fcn B, Rehman NU, Ayaz M, Elhenawy AA, Khan A, Rahman SU, Ali M, Latif A (2025) Synthesis of novel thiazole derivatives containing 3-methylthiophene carbaldehyde as potent anti \u03b1-glucosidase agents: in vitro evaluation, molecular docking, dynamics, MM-GBSA, and DFT studies. J Mol Struct 1321:140070","journal-title":"J Mol Struct"},{"key":"707_CR14","doi-asserted-by":"publisher","first-page":"140136","DOI":"10.1016\/j.molstruc.2024.140136","volume":"1321","author":"A Shakoor","year":"2025","unstructured":"Shakoor A, Fareed G, Ahmad I, Elhenawy AA, Khan M, Fareed N, Al-Olayan E, Abukhadra MR, Alam A, Ibrahim M (2025) Exploring the anti-diabetic activity of benzimidazole containing schiff base derivatives: in vitro \u03b1-amylase, \u03b1-glucosidase inhibitions and in Silico studies. J Mol Struct 1321:140136","journal-title":"J Mol Struct"},{"issue":"43","key":"707_CR15","doi-asserted-by":"publisher","first-page":"31409","DOI":"10.1039\/D4RA05071A","volume":"14","author":"H Aftab","year":"2024","unstructured":"Aftab H, Ullah S, Khan A, Al-Rashida M, Islam T, Alshammari A, Albekairi NA, Taslimi P, Al-Harrasi A, Shafiq Z (2024) Synthesis, in vitro biological evaluation and in silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors. RSC Adv 14(43):31409\u201331421","journal-title":"RSC Adv"},{"issue":"13","key":"707_CR16","first-page":"2920","volume":"55","author":"R Pili","year":"1995","unstructured":"Pili R, Chang J, Partis RA, Mueller RA, Chrest FJ, Passaniti A (1995) The \u03b1-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res 55(13):2920\u20132926","journal-title":"Cancer Res"},{"issue":"21","key":"707_CR17","doi-asserted-by":"publisher","first-page":"11878","DOI":"10.1073\/pnas.96.21.11878","volume":"96","author":"N Zitzmann","year":"1999","unstructured":"Zitzmann N, Mehta AS, Carrou\u00e9e S, Butters TD, Platt FM, McCauley J, Blumberg BS, Dwek RA, Block TM (1999) Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci 96(21):11878\u201311882","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"707_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.54187\/jnrs.1464723","volume":"13","author":"G Korkmaz","year":"2024","unstructured":"Korkmaz G (2024) A review of recent research on the antimicrobial activities of thiosemicarbazone-based compounds. J New Results Sci 13(1):61\u201383","journal-title":"J New Results Sci"},{"issue":"10","key":"707_CR19","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1007\/s10973-023-12029-z","volume":"148","author":"M Pitucha","year":"2023","unstructured":"Pitucha M, Ramos P, Wojtunik-Kulesza K, G\u0142ogowska A, Stefa\u0144ska J, Kowalczuk D, Monika D, Augustynowicz-Kope\u0107 E (2023) Thermal analysis, antimicrobial and antioxidant studies of thiosemicarbazone derivatives. J Therm Anal Calorim 148(10):4223\u20134234","journal-title":"J Therm Anal Calorim"},{"key":"707_CR20","unstructured":"Farooqi R, Ullah S, Khan A, Gurav SS, Mali SN, Aftab H, Al-Sadoon MK, Hsu M-H, Al-Harrasi A, Shafiq Z, Design synthesis, in-vitro and in-silico studies of novel N-heterocycle based hydrazones as \u0391-glucosidase inhibitors. Available at SSRN 4962025"},{"key":"707_CR21","doi-asserted-by":"crossref","unstructured":"Alam M, Abser MN, Kumer A, Bhuiyan MMH, Akter P, Hossain ME, Chakma U (2023) Synthesis, characterization, antibacterial activity of thiosemicarbazones derivatives and their computational approaches: quantum calculation, molecular docking, molecular dynamic, ADMET, QSAR. Heliyon 9(6)","DOI":"10.1016\/j.heliyon.2023.e16222"},{"key":"707_CR22","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez W, Carrasco F, Vaisberg A, Spodine E, Icker M, Krautscheid H, Beyer L, Tamariz-Angeles C, Olivera-Gonzales P (2023) Novel thiosemicarbazone derivatives from furan-2\u2010carbaldehyde: synthesis, characterization, crystal structures, and antibacterial, antifungal, antioxidant, and antitumor activities. J Chem 2023(1):5413236","DOI":"10.1155\/2023\/5413236"},{"key":"707_CR23","doi-asserted-by":"publisher","first-page":"140511","DOI":"10.1016\/j.molstruc.2024.140511","volume":"1322","author":"SB Zahra","year":"2025","unstructured":"Zahra SB, Khan A, Ahmed N, Rafique M, Fatima L, Khan I, Hussain J, Khalid S, Ogaly HA, Ahmed MM (2025) Versatile biological activities of thiosemicarbazones and their metal complexes. J Mol Struct 1322:140511","journal-title":"J Mol Struct"},{"key":"707_CR24","doi-asserted-by":"crossref","unstructured":"Batool Z, Dutt SM, al-Rashida M, Gelsleichter NE, Pelletier J, S\u00e9vigny J, Islam T, Aftab H, Almutairi TM, \u00c7ak\u0131r F (2025) N-hexylsulfonyl Indole based thiosemicarbazones as potent and selective ecto-5\u2032-nucleotidase and NTPDase inhibitors. Bioorg Chem 108717","DOI":"10.1016\/j.bioorg.2025.108717"},{"issue":"1","key":"707_CR25","doi-asserted-by":"publisher","first-page":"22645","DOI":"10.1038\/s41598-024-72858-2","volume":"14","author":"H Aftab","year":"2024","unstructured":"Aftab H, Ullah S, Khan A, Al-Rashida M, Islam T, Dahlous KA, Mohammad S, Kashtoh H, Al-Harrasi A, Shafiq Z (2024) Design, synthesis, in vitro and in Silico studies of novel piperidine derived thiosemicarbazones as inhibitors of dihydrofolate reductase. Sci Rep 14(1):22645","journal-title":"Sci Rep"},{"key":"707_CR26","doi-asserted-by":"publisher","first-page":"111674","DOI":"10.1016\/j.inoche.2023.111674","volume":"159","author":"B Kumar","year":"2024","unstructured":"Kumar B, Devi J, Dubey A, Tufail A, Sharma S (2024) Exploring the antimalarial, antioxidant, anti-inflammatory activities of newly synthesized transition metal (II) complexes bearing thiosemicarbazone ligands: insights from molecular docking, DFT, MESP and ADMET studies. Inorg Chem Commun 159:111674","journal-title":"Inorg Chem Commun"},{"issue":"1","key":"707_CR27","doi-asserted-by":"publisher","first-page":"29378","DOI":"10.1038\/s41598-024-80753-z","volume":"14","author":"TA Farghaly","year":"2024","unstructured":"Farghaly TA, Abbas EM, Abd-Elghaffar HS, Elsayed MA, Elnaggar DH, El-Sayed AF, Abd-Elshafy DN, Mohamed SF (2024) Synthesis, characterization, molecular docking, pharmacokinetics, and molecular dynamics of new bis-thiazoles based on bis-thiosemicarbazone as anti-coxsackievirus. Sci Rep 14(1):29378","journal-title":"Sci Rep"},{"key":"707_CR28","doi-asserted-by":"publisher","first-page":"137669","DOI":"10.1016\/j.molstruc.2024.137669","volume":"1304","author":"S Idris","year":"2024","unstructured":"Idris S, Jan F, Waheed M, Alam A, Ibrahim M, Alasmari AF, Alasmari F, Bo L, Khan M (2024) Multifaceted bioactivity of thiosemicarbazide derivatives: synthesis, characterization, and DFT investigations on Inhibition of \u03b1-amylase, hydroxyl radical scavenging, and iron chelating activities with molecular docking insights. J Mol Struct 1304:137669","journal-title":"J Mol Struct"},{"key":"707_CR29","doi-asserted-by":"publisher","first-page":"139614","DOI":"10.1016\/j.molstruc.2024.139614","volume":"1320","author":"W Shoukat","year":"2025","unstructured":"Shoukat W, Hussain M, Ali A, Shafiq N, Chughtai AH, Shakoor B, Moveed A, Shoukat MN, Milo\u0161evi\u0107 M, Mohany M, Design (2025) Synthesis, characterization and biological screening of novel thiosemicarbazones and their derivatives with potent antibacterial and antidiabetic activities. J Mol Struct 1320:139614","journal-title":"J Mol Struct"},{"key":"707_CR30","doi-asserted-by":"publisher","first-page":"138459","DOI":"10.1016\/j.molstruc.2024.138459","volume":"1311","author":"F Jan","year":"2024","unstructured":"Jan F, Idris S, Waheed M, Alam A, Alasmari AF, Alasmari F, Khan M (2024) Thiosemicarbazone derivatives as potent antidiabetic agents: synthesis, in vitro, molecular docking and DFT investigations. J Mol Struct 1311:138459","journal-title":"J Mol Struct"},{"issue":"12","key":"707_CR31","doi-asserted-by":"publisher","first-page":"101874","DOI":"10.1016\/j.jsps.2023.101874","volume":"31","author":"M Waheed","year":"2023","unstructured":"Waheed M, Idris S, Jan F, Alam A, Ibrahim M, AlAsmari AF, Alharbi M, Alasmari F, Khan M (2023) Exploring the synthesis, structure, spectroscopy and biological activities of novel 4-benzylidene-1-(2-(2, 4-dichloro phenyl) acetyl) Thiosemicarbazide derivatives: an integrated experimental and theoretical investigation. Saudi Pharm J 31(12):101874","journal-title":"Saudi Pharm J"},{"key":"707_CR32","doi-asserted-by":"crossref","unstructured":"Ullah N, Alam A, Zainab; Elhenawy AA, Naz S, Islam MS, Ahmad S, Shah SAA, Ahmad M (2024) Investigating novel thiophene carbaldehyde based thiazole derivatives as potential hits for diabetic management: synthesis, in vitro and in Silico approach. ChemistrySelect 9(8):e202304601","DOI":"10.1002\/slct.202304601"},{"key":"707_CR33","doi-asserted-by":"publisher","first-page":"107501","DOI":"10.1016\/j.bioorg.2024.107501","volume":"150","author":"SU Rahman","year":"2024","unstructured":"Rahman SU, Alam A, Parveen Z, Assad M, Shah SAA, Rafiq H, Ayaz M, Latif A, Umar MN, Ali M (2024) Novel acyl Hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: synthesis, in vitro \u03b1-amylase, \u03b1-glucosidase Inhibition and anti-glycating activity with molecular docking insights. Bioorg Chem 150:107501","journal-title":"Bioorg Chem"},{"issue":"23","key":"707_CR34","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.4155\/fmc-2023-0232","volume":"15","author":"F Talab","year":"2023","unstructured":"Talab F, Zainab; Alam A, Ali M, Rehman NU, Ullah S, Halim SA, Islam MS, Khan A, Latif A (2023) Polyhydroquinoline derivatives for diabetic management: synthesis, in vitro and in Silico approaches. Future Med Chem 15(23):2195\u20132208","journal-title":"Future Med Chem"},{"key":"707_CR35","doi-asserted-by":"publisher","first-page":"138671","DOI":"10.1016\/j.molstruc.2024.138671","volume":"1312","author":"S Gul","year":"2024","unstructured":"Gul S, Elhenawy AA, Ali Q, Rehman MU, Alam A, Khan M, AlAsmari AF, Alasmari F (2024) Discovering the anti-diabetic potential of thiosemicarbazone derivatives: in vitro \u03b1-glucosidase, \u03b1-amylase inhibitory activities with molecular docking and DFT investigations. J Mol Struct 1312:138671","journal-title":"J Mol Struct"},{"issue":"5","key":"707_CR36","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1021\/acsomega.2c08108","volume":"8","author":"M Khan","year":"2023","unstructured":"Khan M, Gohar H, Alam A, Wadood A, Shareef A, Ali M, Khalid A, Abdalla AN, Ullah F (2023) Para-substituted thiosemicarbazones as cholinesterase inhibitors: synthesis, in vitro biological evaluation, and in silico study. ACS Omega 8(5):5116\u20135123","journal-title":"ACS Omega"},{"key":"707_CR37","doi-asserted-by":"crossref","unstructured":"Essid M, Alam A, Fareed G, Rahman S, Ahmad I, Zghab I, Alnakhli ZH, Ali A, Kamal M, Khan M (2025) Discovering the cholinesterase inhibitory potential of thiosemicarbazone derivatives through in vitro, molecular docking, kinetics, and dynamics studies. Med Chem (Shariqah (United Arab Emirates))","DOI":"10.2174\/0115734064375028250427171931"},{"key":"707_CR38","doi-asserted-by":"crossref","unstructured":"Alharthy RD, Khalid S, Fatima S, Ullah S, Khan A, Mali SN, Jawarkar RD, Dhabarde SS, Kashtoh H, Taslimi P (2024) Synthesis of the chromone-thiosemicarbazone scaffold as promising \u03b1\u2010glucosidase inhibitors: an in vitro and in silico approach toward antidiabetic drug design. Arch Pharm e2400140","DOI":"10.1002\/ardp.202400140"},{"key":"707_CR39","doi-asserted-by":"crossref","unstructured":"Ullah H, Khan S, Rahim F, Taha M, Iqbal R, Sarfraz M, Shah SAA, Sajid M, Awad MF, Omran A (2022) Benzimidazole bearing thiosemicarbazone derivatives act as potent \u03b1-amylase and \u03b1-glucosidase inhibitors; synthesis, bioactivity screening and molecular docking study. Molecules 27(20):6921","DOI":"10.3390\/molecules27206921"},{"issue":"1","key":"707_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.26650\/IstanbulJPharm.2023.1164443","volume":"53","author":"H \u015eahin","year":"2023","unstructured":"\u015eahin H, Bing\u00fcl AA, \u015eeng\u00fcl \u0130F, Bing\u00fcl M (2023) Biological and computational evaluation of carbazole-based bis-thiosemicarbazones: a selective enzyme Inhibition study between \u03b1-amylase and \u03b1-glucosidase. \u0130stanbul J Pharm 53(1):39\u201344","journal-title":"\u0130stanbul J Pharm"},{"issue":"42","key":"707_CR41","doi-asserted-by":"publisher","first-page":"e202302936","DOI":"10.1002\/slct.202302936","volume":"8","author":"A Korkmaz","year":"2023","unstructured":"Korkmaz A, Bursal E, Kurtay G (2023) In vitro and in silico evaluation of amylase, tyrosinase, and pancreatic lipase inhibitions of novel benzothiazole-sulfonate derivatives. ChemistrySelect 8(42):e202302936","journal-title":"ChemistrySelect"},{"key":"707_CR42","doi-asserted-by":"publisher","first-page":"134119","DOI":"10.1016\/j.molstruc.2022.134119","volume":"1271","author":"TP Mokoena","year":"2023","unstructured":"Mokoena TP, Maluleka MM, Mampa RM, Mphahlele MJ, Monchusi BA (2023) Synthesis, crystal structures, spectroscopic characterization and in vitro evaluation of the 4-sulfono-3-methoxycinnamaldehydes as potential \u03b1-glucosidase and\/or \u03b1-amylase inhibitors. J Mol Struct 1271:134119","journal-title":"J Mol Struct"},{"issue":"78","key":"707_CR43","doi-asserted-by":"publisher","first-page":"49436","DOI":"10.1039\/C7RA09053F","volume":"7","author":"C Shen","year":"2017","unstructured":"Shen C, Yang M, Xu J, Chen C, Zheng K, Shen J, Zhang P (2017) Iodobenzene-catalyzed synthesis of Aryl sulfonate esters from aminoquinolines via remote radical C\u2013O cross-coupling. RSC Adv 7(78):49436\u201349439","journal-title":"RSC Adv"},{"issue":"19","key":"707_CR44","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.3390\/molecules26195895","volume":"26","author":"E Bisz","year":"2021","unstructured":"Bisz E (2021) Iron-catalyzed cross-coupling reactions of alkyl grignards with aryl chlorobenzenesulfonates. Molecules 26(19):5895","journal-title":"Molecules"},{"issue":"2","key":"707_CR45","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00044-021-02837-z","volume":"31","author":"S \u015eenkarde\u015f","year":"2022","unstructured":"\u015eenkarde\u015f S, \u0130hsan Han M, G\u00fcrbo\u011fa M, \u00d6zakpinar \u00d6B (2022) G\u00fcniz K\u00fc\u00e7\u00fckg\u00fczel, \u015e. Synthesis and anticancer activity of novel hydrazone linkage-based Aryl sulfonate derivatives as apoptosis inducers. Med Chem Res 31(2):368\u2013379","journal-title":"Med Chem Res"},{"issue":"4","key":"707_CR46","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jccs.202100511","volume":"69","author":"A Kamal\u0131","year":"2022","unstructured":"Kamal\u0131 A, \u00c7akmak R, Bo\u011fa M (2022) Anticholinesterase and antioxidant activities of novel heterocyclic schiff base derivatives containing an Aryl sulfonate moiety. J Chin Chem Soc 69(4):731\u2013743","journal-title":"J Chin Chem Soc"},{"key":"707_CR47","doi-asserted-by":"crossref","unstructured":"Kurban MG, \u00c7akmak R, Ba\u015faran E, T\u00fcrkmeno\u011flu B, \u015eent\u00fcrk M (2024) Synthesis of new sulfonamide derivatives: investigation of their interactions with carbonic anhydrase and cholinesterase enzymes by in vitro and in Silico evaluations. J Mol Struct 138798","DOI":"10.1016\/j.molstruc.2024.138798"},{"key":"707_CR48","doi-asserted-by":"crossref","unstructured":"Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y (2012) admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. ACS Publications","DOI":"10.1021\/ci300367a"},{"issue":"W1","key":"707_CR49","doi-asserted-by":"publisher","first-page":"W432","DOI":"10.1093\/nar\/gkae298","volume":"52","author":"Y Gu","year":"2024","unstructured":"Gu Y, Yu Z, Wang Y, Chen L, Lou C, Yang C, Li W, Liu G, Tang Y (2024) admetSAR3. 0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties. Nucleic Acids Res 52(W1):W432\u2013W438","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"707_CR50","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1021\/ci034134i","volume":"43","author":"T Hou","year":"2003","unstructured":"Hou T, Xu X (2003) ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors. J Chem Inf Comput Sci 43(6):2137\u20132152","journal-title":"J Chem Inf Comput Sci"},{"key":"707_CR51","doi-asserted-by":"publisher","first-page":"131204","DOI":"10.1016\/j.molstruc.2021.131204","volume":"1246","author":"M Arshad","year":"2021","unstructured":"Arshad M, Ahmed K, Bashir M, Kosar N, Kanwal M, Ahmed M, Khan HU, Khan S, Rauf A, Waseem A (2021) Synthesis, structural properties and potent bioactivities supported by molecular docking and DFT studies of new hydrazones derived from 5-chloroisatin and 2-thiophenecarboxaldehyde. J Mol Struct 1246:131204","journal-title":"J Mol Struct"},{"key":"707_CR52","doi-asserted-by":"publisher","first-page":"135383","DOI":"10.1016\/j.molstruc.2023.135383","volume":"1284","author":"K Ahmed","year":"2023","unstructured":"Ahmed K, Bashir M, Bano R, Sarfraz M, Khan HU, Khan S, Sharif A, Waseem A, Gilani MA, Batool K (2023) Potent heteroaromatic hydrazone based 1, 2, 4-triazine motifs: synthesis, anti-oxidant activity, cholinesterase inhibition, quantum chemical and molecular docking studies. J Mol Struct 1284:135383","journal-title":"J Mol Struct"},{"key":"707_CR53","doi-asserted-by":"crossref","unstructured":"Korkmaz A, Bursal E (2022) Synthesis, biological activity and molecular docking studies of novel sulfonate derivatives bearing salicylaldehyde. Chem Biodivers 19(6):e202200140","DOI":"10.1002\/cbdv.202200140"},{"issue":"1","key":"707_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12010-021-03791-7","volume":"194","author":"LE Mendie","year":"2022","unstructured":"Mendie LE, Hemalatha S (2022) Molecular docking of phytochemicals targeting GFRs as therapeutic sites for cancer: an in Silico study. Appl Biochem Biotechnol 194(1):215\u2013231","journal-title":"Appl Biochem Biotechnol"},{"key":"707_CR55","unstructured":"using AutoDock D Ethyl acetate extract of smilax glabra Roxb roots and its major active compound Astilbin promote osteoblastogenesis in vitro by upregulating bone cell differentiation-associated genes"},{"issue":"10","key":"707_CR56","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1007\/s10910-023-01558-5","volume":"62","author":"AK Saxena","year":"2024","unstructured":"Saxena AK, Gupta AK, Bhatia KS (2024) Physicochemical significance of ChemDraw and Dragon computed parameters: correlation studies in the sets with aliphatic and aromatic substituents. J Math Chem 62(10):2430\u20132455","journal-title":"J Math Chem"},{"issue":"2","key":"707_CR57","first-page":"49","volume":"11","author":"K Lakshmanan","year":"2019","unstructured":"Lakshmanan K, Balasubramanian HB, Aiyalu R, Ramasamy A (2019) Molecular Docking studies of flavones in Gentianaceae family against liver corrective targets. Res J Pharmacogn Phytochem 11(2):49\u201353","journal-title":"Res J Pharmacogn Phytochem"},{"issue":"2","key":"707_CR58","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10930-023-10163-z","volume":"43","author":"M Sarfraz","year":"2024","unstructured":"Sarfraz M, Aziz M, Afzal S, Channar PA, Alsfouk BA, Kandhro GA, Hassan S, Sultan A, Hamad A, Arafat M (2024) Repurposing of strychnine as the potential inhibitors of Aldo\u2013keto reductase family 1 members B1 and B10: computational modeling and Pharmacokinetic analysis. Protein J 43(2):207\u2013224","journal-title":"Protein J"},{"issue":"1","key":"707_CR59","doi-asserted-by":"publisher","first-page":"20240064","DOI":"10.1515\/chem-2024-0064","volume":"22","author":"F Siddique","year":"2024","unstructured":"Siddique F, Daoui O, Ayoub M, Elkhattabi S, Chtita S, Afzal S, Mohyuddin A, Kaukab I, Ejaz SA, Salamatullah AM (2024) Identification and in silico screening of natural phloroglucinols as potential PI3K\u03b1 inhibitors: a computational approach for drug discovery. Open Chem 22(1):20240064","journal-title":"Open Chem"},{"key":"707_CR60","doi-asserted-by":"crossref","unstructured":"Kameswaran S, Swapna B, Ramakrishna M, Ramesh B, Bangeppagari M (2024) Different tools for modern drug discovery research. In: Traditional resources and tools for modern drug discovery: ethnomedicine and Pharmacology. Springer, pp 55\u201376","DOI":"10.1007\/978-981-97-4600-2_3"},{"issue":"8","key":"707_CR61","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s12033-023-00831-x","volume":"66","author":"AM da Fonseca","year":"2024","unstructured":"da Fonseca AM, Caluaco BJ, Madureira JMC, Cabongo SQ, Gaieta EM, Djata F, Colares RP, Neto MM, Fernandes CFC, Marinho GS (2024) Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking, and approach with molecular dynamics, RMSD, RMSF, H-bond, SASA and MMGBSA. Mol Biotechnol 66(8):1919\u20131933","journal-title":"Mol Biotechnol"},{"issue":"11","key":"707_CR62","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/biom12111612","volume":"12","author":"MS Bilal","year":"2022","unstructured":"Bilal MS, Ejaz SA, Zargar S, Akhtar N, Wani TA, Riaz N, Aborode AT, Siddique F, Altwaijry N, Alkahtani HM (2022) Computational investigation of 1, 3, 4 oxadiazole derivatives as lead inhibitors of VEGFR 2 in comparison with EGFR: density functional theory, molecular Docking and molecular dynamics simulation studies. Biomolecules 12(11):1612","journal-title":"Biomolecules"},{"issue":"1","key":"707_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40203-025-00309-5","volume":"13","author":"S Noor","year":"2025","unstructured":"Noor S, Aljasir MA, Bashir M, Khan K, Ahmad S, Abideen SA, Khan S, Siddique F, Ahmad H, Ghani K (2025) Multi-scale computational modeling to identify novel chemical scaffolds as trehalose-6-phosphate phosphatase inhibitors to combat burkholderia Pseudomallei. Silico Pharmacol 13(1):21","journal-title":"Silico Pharmacol"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00707-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00707-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00707-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:06:10Z","timestamp":1764083170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00707-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00707-z","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"1"}}